Cargando...
Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
The first approved dengue vaccine has now been licensed in six countries. We propose that this live attenuated vaccine acts like a silent natural infection in priming or boosting host immunity. A transmission dynamic model incorporating this hypothesis fits recent clinical trial data well and predic...
Guardado en:
| Publicado en: | Science |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5268127/ https://ncbi.nlm.nih.gov/pubmed/27701113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aaf9590 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|